Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name	Market Cap	Price to Earnings TTM	Dividend Yield % TTM
ALPNAlpine Immune Sciences	$4.46bn	n/a	n/a
ALKSAlkermes	$4.20bn	7.05	n/a
CRNXCrinetics Pharmaceuticals	$4.15bn	n/a	n/a
MRTXMirati Therapeutics	$4.12bn	n/a	n/a
DYNDyne Therapeutics	$4.11bn	n/a	n/a
IMVTImmunovant	$4.09bn	n/a	n/a
ALKSVAlkermes	$4.05bn	18.02	n/a
IBRXImmunitybio	$4.00bn	n/a	n/a
RAREUltragenyx Pharmaceutical	$3.98bn	n/a	n/a
RYZBRayzebio	$3.81bn	n/a	n/a
GHGuardant Health	$3.76bn	n/a	n/a
CBAYCymaBay Therapeutics	$3.73bn	n/a	n/a
MRUSMerus NV	$3.72bn	n/a	n/a
ALVOAlvotech SA	$3.61bn	n/a	n/a
ARWRArrowhead Pharmaceuticals	$3.51bn	n/a	n/a
IDYAIdeaya Biosciences	$3.40bn	n/a	n/a
ACLXArcellx	$3.35bn	n/a	n/a
TGTXTG Therapeutics	$3.25bn	95.24	n/a
XENEXenon Pharmaceuticals	$3.22bn	n/a	n/a
BHVNBiohaven	$3.18bn	n/a	n/a